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Research
AbstrACt
Objective Compare arthroscopic partial meniscectomy to 
a true sham intervention.
Methods Sham-controlled superiority trial performed in 
three county hospitals in Denmark comparing arthroscopic 
partial meniscectomy to skin incisions only in patients 
aged 35–55 years with persistent knee pain and an MRI-
confirmed medial meniscus lesion. A computer-generated 
table of random numbers generated two comparison 
groups. Participants and outcome assessors were blinded 
to group allocation. Exclusions were locking knees, high-
energy trauma or severe osteoarthritis. Outcomes were 
collected at baseline, 3 and 24 months. We hypothesised 
no difference between groups. The primary outcome was 
the between-group difference in change from baseline to 
2 years in the mean score across all five normalised Knee 
injury and Osteoarthritis Outcome Score (KOOS) subscales 
(KOOS
5).
results Forty-four patients (of the estimated 72) 
underwent randomisation; 22 in each group. Sixteen 
participants (36%) were non-blinded and eight participants 
(36%) from the sham group crossed over to the surgery 
group prior to the 2-year follow-up. At 2 years, both groups 
reported clinically relevant improvements (surgery 21.8, 
skin incisions only 13.6), the mean difference between 
groups was 8.2 in favour of surgery, which is slightly less 
than the cut-off of 10 prespecified to represent a clinically 
relevant difference; judged by the 95% CI (−3.4 to 19.8), 
a possibility of clinically relevant difference could not 
be excluded. In total, nine participants experienced 11 
adverse events; six in the surgery group and three in the 
skin-incisions-only group.
Conclusion We found greater improvement from 
arthroscopic partial meniscectomy compared with skin 
incisions only at 2 years, with the statistical uncertainty 
of the between-group difference including what could 
be considered clinically relevant. Because of the study 
being underpowered, nearly half in the sham group being 
non-blinded and one-third crossing over to surgery, 
the results cannot be generalised to the greater patient 
population.
trial registration number NCT01264991.
IntrOduCtIOn
Knee pain is responsible for a large and 
increasing disease burden, including 
in middle-aged and older people.1 Recom-
mended management strategies include 
patient education, exercise, weight loss, 
analgesics and surgery.2–4 Notwithstanding it 
being very commonly practised, systematic 
reviews have found no added benefit from 
knee arthroscopic surgery in the chron-
ically painful knee of middle-aged or older 
persons.5 6 While there are at least seven 
randomised controlled trials of arthroscopic 
surgery in patients with knee osteoarthritis, 
only three have been done in patients with a 
meniscal tear but without established osteo-
arthritis.7–9 Patients included in these studies 
were middle-aged (35 and older) with mean 
ages ranging from 49 to 54 years.7–9 Two of 
these studies used exercise as the compar-
ator, either head-to-head9 or in an additive 
design.7 Only one of these studies was able 
to control for non-specific (placebo) effects 
by comparing arthroscopic partial meniscec-
tomy to diagnostic arthroscopy.8 However, 
some argue that diagnostic arthroscopy may 
strengths and limitations of this study
 ► This is only the second trial to compare arthroscopic 
partial meniscectomy with sham surgery intervention 
in patients with MRI-verified meniscus lesion.
 ► This trial includes younger patients than previous 
trials of arthroscopic surgery.
 ► With the study being underpowered, nearly half in 
the sham group being non-blinded and one-third 
crossing over to surgery, the results cannot be 
generalised to the greater patient population.
 ► Our trial confirms the challenges of performing 
sham-controlled trials of surgery.
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have a treatment effect in itself since the joint is entered 
with instruments and lavage is performed.10 
While the number of arthroscopic procedures, with or 
without meniscectomy, to treat people with established 
osteoarthritis may have decreased over the last decade,11 12 
the number of arthroscopic partial meniscectomies has 
risen.11 One reason for the continued high use of knee 
arthroscopy may be the few sham knee arthroscopy 
trials,8 13 with only one for arthroscopic partial menis-
cectomy.8 The non-specific effects of surgery and other 
invasive procedures are generally large.14 Particularly in 
the field of pain-related conditions, more evidence from 
randomised placebo-controlled trials is required to avoid 
continuation of ineffective treatments.15 16 To compare 
arthroscopic partial meniscectomy to a true sham inter-
vention, we performed a randomised controlled trial 
comparing arthroscopic partial meniscectomy to skin 
incisions only in middle-aged patients with persistent 
knee pain and an MRI-verified meniscus lesion.
MethOds
trial design
We conducted this blinded randomised sham-controlled 
multicentre trial at three county hospitals in Denmark 
from February 2011 to March 2015. Details of the trial 
design and methods are published.17 The study was 
consistent with the Declaration of Helsinki. The first and 
second authors vouch for the accuracy and completeness 
of the reported data, analyses and adherence to the previ-
ously published registration ( ClinicalTrials. gov number 
NCT01264991), protocol17 and the corresponding final 
statistical analysis plan (online supplementary appendix). 
All patients provided written informed consent. On 
entering the study, patients were informed that if they 
were randomised to sham treatment and did not experi-
ence satisfactory pain relief, they could cross over to the 
other procedure (arthroscopic partial meniscectomy) by 
3 months or later.
Participants
According to the protocol, eligible patients were between 
35 and 55 years of age with knee pain for more than 2 
months and an MRI-confirmed medial meniscus lesion, 
but without significant trauma. Patients were excluded 
if they had experienced prolonged episodes of inability 
to fully extend the knee, having had high-energy trauma, 
grade 3–4 osteoarthritis on the Kellgren and Lawrence 
classification or knee surgery within the previous 2 years. 
Detailed inclusion and exclusion criteria are provided in 
online supplementary appendix table 1.
blinding and randomisation
All study personnel and participants were blinded to the 
intervention, except for the surgeons and other operating 
theatre personnel, who did not have any other role in 
the study. Two comparison groups were generated by an 
external coinvestigator using simple randomisation with 
an equal allocation ratio (1:1), by referring to a comput-
er-generated table of random numbers. Block randomi-
sation with blocks of four or six was used, and patients 
were stratified for treatment centre. Once the patient 
was sedated, the surgeon retrieved a sealed consecutively 
numbered envelope containing the patient’s assigned 
intervention from a briefcase kept just outside the actual 
operating theatre.
Protocol deviations
When registering the trial, we were concerned about 
dropouts and therefore aimed to recruit 100 patients 
despite only 72 being needed to obtain a power of 80%.17 
During the trial recruitment period, several relevant 
studies on knee arthroscopy were published and received 
substantial media attention in Denmark. This greatly 
impacted the ability to recruit patients to the study. As 
a consequence, we arranged for a third centre to help 
with recruitment. Despite large efforts, this centre was 
able to recruit only two patients for the study. Therefore, 
for feasibility and ethical reasons, we closed the recruit-
ment on 29 January 2015 after a recruitment period 
of 51 months, and report the results for the 44 patients 
recruited, enrolled and randomised. Considering the 
nature and rarity of a sham-controlled surgical trial, we 
considered it important and ethically prudent to make 
the results publicly available. Minor protocol deviations 
were that the Knee injury and Osteoarthritis Outcome 
Score (KOOS) questionnaire was not completed by the 
patients prior to crossing over to the surgery arm, and 
we did not play a video showing a standard arthroscopy 
during the sham procedure.
Operative and postoperative procedures
In both groups, all procedures were performed with 
general anaesthesia combined with local anaesthesia. The 
knee was tested for stability, and two skin incisions were 
made. Ten experienced surgeons in their final year of 
residency, or attending orthopaedic surgeons, performed 
the procedures.
In the arthroscopic partial meniscectomy group, a 
tourniquet was used at the discretion of the surgeon. 
Normal procedures were followed, and the arthroscope 
was inserted. The strategy for the meniscectomy was to 
preserve as much tissue as possible. No other surgical 
procedures were performed. A standard protocol was 
used to document perioperative findings in cartilage and 
the medial and lateral menisci.
In the skin-incisions-only group, following the initial 
common procedures, the knee was manipulated as if real 
arthroscopy was performed; the spillage of water and all 
other equipment needed for an arthroscopy was used. 
No instruments were entered into the incisions to mini-
mise the risk of a deep infection, osteochondral lesion or 
unwanted intervention by the surgeon.
In both groups, patients were handed the same stan-
dard care folder including postoperative advice and a 
home-based exercise programme. At 1 week, biking, 
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swimming and fast walking were recommended, and at 
2–3 weeks, more intense biking and jogging were recom-
mended. For the first postoperative week, seven different 
non-weight-bearing exercises to improve lower extremity 
function and knee range of motion were suggested, and 
an additional three weight bearing thereafter. All exer-
cises were recommended to be performed 10–15 times 
three times daily (online supplementary appendix).
Outcome measures
All outcomes were collected at baseline, and at 3 and 24 
months’ follow-ups. The prespecified primary outcome 
measure was the between-group difference in change 
from baseline to 2 years in the mean score across all five 
normalised KOOS subscales, covering pain, symptoms, 
activities of daily living, sport and recreation function, and 
quality of life (KOOS5). Each subscale consists of multiple 
items scored on a 5-point Likert scale; the KOOS5 ranges 
from 0 to 100, worst to best. KOOS is a valid, reliable and 
responsive measure of patient-reported outcomes for 
patients having knee arthroscopy.18 19 To minimise bias, 
questionnaires were filled out at home at all time points.
Secondary patient-reported outcome measures were 
the five individual KOOS subscales, the Short-Form 
36-item (SF-36) Physical and Mental Component Scores, 
a seven-step Global Perceived Effect (GPE) score (ranging 
from much worse to much better) and the EuroQol-
Group 5-dimension 3-level (EQ-5D-3L). Three objective 
measures of lower extremity function were collected, with 
elastic stockings concealing both knees and randomisa-
tion of first leg to be tested at each visit to minimise bias. 
The best value for each test was recorded, and the details 
of the testing procedures were described.17 Maximum 
knee extension force was recorded as maximal voluntary 
torque per kg of body mass and measured sitting using a 
hand-held dynamometer. The one-leg hop test, measured 
in centimetres, is a measure of function at a level above 
daily living and recommended for middle-aged subjects 
at risk of osteoarthritis.20 The maximum number of 
one-legged knee-bends in 30 s resembles stepping down 
a stair and was included as a measure of one-legged func-
tion at the level of daily living valid and reliable in patients 
who had undergone meniscectomy.21
statistical analysis
The primary analysis of the primary outcome measure 
(KOOS5) was conducted according to the intention-to-
treat (ITT) principle; the ITT principle implies that all 
randomised patients should be analysed according to the 
treatment to which the patient was allocated, irrespective 
of whether they received this or some other treatment, or 
no treatment at all.
The statistical analyses were based on a repeated 
linear mixed model including all patients with a baseline 
assessment, with both fixed (group, centre and time) 
and random (patient identity) factors. We prespecified 
the primary analyses in this trial to be based on the ‘as 
observed cases’ while respecting the randomisation (ie, 
no data imputation).22 To explore the robustness of 
these primary analyses, the Baseline Observation Carried 
Forward (ie, null responder) imputation techniques, as 
well as the ‘Per Protocol’ population, was also applied for 
the purpose of sensitivity analysis.
results
Characteristics of the patients
Of the 235 patients who were eligible for enrolment 
prior to having an MRI scan, 135 declined to participate 
(figure 1). Of the 100 willing to participate, 24 did not 
have a meniscal lesion on MRI, and 32 declined after 
a meniscal lesion was confirmed on MRI. Thus, a total 
of 44 patients were enrolled and underwent randomisa-
tion; 22 were randomised to arthroscopic partial menis-
cectomy and 22 to skin incisions only (sham procedure). 
The baseline characteristics of the two groups were 
well balanced (table 1). All underwent the assigned 
intervention.
Missing data
Due to an administrative error, two sets of questionnaires 
(from the skin-incisions group) were missing at baseline. 
At 2 years, two (other) participants were lost to follow-up, 
both from the skin-incisions group (these two subjects 
crossed over to arthroscopic surgery between 3 and 24 
months), yielding a follow-up rate of 96%. Functional 
testing was not performed in 3 patients at baseline and 
in 10 patients at the 2-year follow-up (figure 1). The most 
common reason given was long travel distance to the 
test centre, however notably 8 out of 10 participants not 
tested at follow-up were previously non-blinded.
non-blinding and cross-over to arthroscopic partial 
meniscectomy
In total, 16 participants (36%; 6 from the arthroscopy 
group and 10 from the sham group) were non-blinded 
prior to the 2-year follow-up. One patient from the 
skin-incisions group was non-blinded by a nurse directly 
following surgery. Prior to 3 months, two additional 
patients were non-blinded by the treating surgeon 
because of suspicion of an adverse event (one infection 
and one thrombosis, neither later confirmed, both from 
the arthroscopy group) and one because of persisting 
pain (from the skin-incisions group). Between 3 and 24 
months, two from the arthroscopy group and eight from 
the sham group were non-blinded by the treating surgeon 
because of persisting pain. One from the arthroscopy 
group was informed about group allocation by his general 
practitioner (GP) checking the digital medical records, 
and one participant accessed the information himself in 
his digital medical records.
Arthroscopic partial meniscectomy was performed in 
8 out of 10 non-blinded cases in the skin-incisions group, 
yielding a cross-over rate of 36%.
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Primary outcome, Itt population
At 3 months, both groups reported clinically important 
and statistically significant improvements of 13.4 and 
14.9 points in KOOS5 favouring the skin-incisions group 
only, with no significant difference between groups 
(1.5, 95% CI: −10.0 to 13.0, P=0.796). At 2 years, the 
primary endpoint of this trial, the group randomised to 
arthroscopic partial meniscectomy continued to improve 
and reported a clinically relevant improvement of 21.8 
points in KOOS5compared with baseline. The group 
randomised to skin incisions only did not improve further 
from 3 months; the average improvement from baseline 
was however still clinically relevant, 13.6 points. The 
mean difference between groups at 2 years was 8.2, which 
is slightly less than the cut-off of 10 prespecified to repre-
sent a clinically relevant difference (table 2 and figure 2). 
The 95% CI (−3.4 to 19.8) included the predefined cut-off 
for a clinically relevant difference (table 2 and figure 3).
secondary and other outcomes
The individual KOOS subscales at 2 years largely 
supported the primary outcome with between-group 
differences of 11.5 for quality of life (QOL), 9.9 for pain, 
9.0 for ADL, 6.6 for symptoms and 5.6 for sport/recre-
ation, all in favour of arthroscopic partial meniscectomy. 
The mean differences for QOL and pain were 10 or 
Figure 1 Study flow.
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Table 1 Patient characteristics
Variable N
Arthroscopic 
partial 
meniscectomy
N
Skin incisions 
only
N
Total
Min MaxMean (SD) Mean (SD) Mean (SD)
Person demographics
  Age, years 22 47.2 (5.9) 22 46.4 (5.5) 44 46.8 (5.7) 37.5 55.8
  Females, n (%) 22 9 (41) 22 12 (55) 44 21 (48) 
  Height, cm 22 176 (9) 22 174 (12) 44 175 (11) 156 194
  Weight, kg 22 85.6 (14.6) 22 79.7 (19.5) 44 82.6 (17.3) 52 120
  BMI, kg/m2 22 27.6 (3.6) 22 26 (3.9) 44 26.8 (3.8) 18.6 33.5
Knee examinations 
  Kellgren and Lawrence grade (0 – 4) 22 22 44 
   0, n (%) 9 (41) 10 (45) 19 (43)
   1, n (%) 9 (41) 8 (36) 17 (39)
   2, n (%) 4 (18) 4 (18) 8 (18)
   3, n (%) 0 (0) 0 (0) 0 (0)
   4, n (%) 0 (0) 0 (0) 0 (0)
  Joint line tenderness, n (%) 21 21 (100) 22 20 (91) 43 41 (95)
  Positive results of McMurray test, n (%) 21 17 (81) 22 17 (77) 43 34 (79)
  Swelling present, n (%) 21 11 (52) 22 8 (36) 43 19 (44)
  Knee extension 21 22 43
   Full extension, n (%) 18 (86) 21 (95) 39 (91)
   Small extension deficit <10°, n (%) 3 (14) 1 (5) 4 (9)
  Knee flexion 21 22 43
  Full flexion, n (%) 17 (81) 14 (64) 31 (72)
  Small flexion deficit <10°, n (%) 3 (14) 6 (27) 9 (21)
  Large flexion deficit, n (%) 1 (5) 2 (9) 3 (7)
Findings during arthroscopy
  Meniscus operated on (medial/lateral/both), 
n (%) 
21 (20/0/1) (95/0/50) 
  Meniscus resection
   Extent of resection (1–3 regions), median 
(range)
1 (1– 3) 
   Anterior region, n (%) 1 (5) 
   Mid region, n (%) 1 (5) 
   Posterior region, n (%) 19 (90) 
  Cartilage status: (worst ICRS grade, 0-IVb)
   Tibia, median (range) 0 (0– IIIb) 
   Femur, median (range) 0.5 (0– IIIa) 
   Patella, median (range) 0 (0– II) 
Patient-reported data 
  Duration of pain, months, median (IQR) 22 5.0 (2.0 – 6.0) 22 3.5 (2.0 – 6.0) 44 4.0 (2.0 – 6.0) 2 60 
KOOS
  KOOS5 (0–100) 22 51.2 (15.6) 20 44.8 (19.9) 42 48.1 (17.8) 21 88
  Pain (0–100) 22 55.1 (15.4) 20 45.9 (22) 42 50.7 (19.2) 11 86
  Symptoms (0–100) 22 62.8 (17.7) 20 59.9 (20.6) 42 61.4 (18.9) 32 100
  Function in daily living (0–100) 22 64.9 (19.9) 20 56.5 (22.3) 42 60.9 (21.3) 25 100
  Function in sport and recreation (0–100) 22 35 (23) 20 25.2 (26.3) 42 30.4 (24.9) 0 85
  Knee-related quality of life (0–100) 22 38.7 (15.4) 20 36.6 (20.2) 42 37.7 (17.6) 6 75
Continued
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greater (depending on rounding), a suggested cut-off for 
being clinically relevant (figure 3). None of these differ-
ences were statistically significant (table 2).
There were no statistically significant between-group 
differences in EQ-5D, SF-36, GPE score, muscle strength 
or physical performance measures. In the surgery group, 
67% reported a GPE response of ‘better’ or ‘much better’, 
compared with 37% in the skin-incisions group, P=0.059 
(table 2).
sensitivity analyses
The sensitivity analyses at 2 years largely supported 
the primary analyses (figure 3, online supplementary 
appendix tables 2 and 3). Notably, in the per-protocol 
analysis, a non-significant 9.7-point greater improvement 
in KOOS5 score was seen at 3 months in the skin-incision 
group (figure 2).
Adverse events
Crossing over to arthroscopic partial meniscectomy in 
the skin-incisions group was not considered an adverse 
event. Four knee-related adverse events were recorded, of 
which two were regarded as serious (two rearthroscopies; 
one partial meniscectomy and one anterior cruciate liga-
ment reconstruction), one cutaneous nerve lesion and 
one mild knee swelling), all in the surgery group. In total, 
seven other adverse events in five participants, two in the 
surgery group and three in the skin-incisions group, were 
recorded (chest pain, finger injury, nausea, dizziness and 
kidney stone) including two regarded as serious (abdom-
inal surgery and malignant melanoma).
dIsCussIOn
We included middle-aged (mean 47.2 years, range 
37.5–55.8), slightly overweight (body mass index 26.8) 
patients with typical symptoms. Our patient sample is the 
youngest thus far included in a controlled randomised 
trial of arthroscopic surgery of meniscal tear. While they 
suffered from, on average, moderate knee pain and 
daily functional limitations (KOOS: pain 51, symptoms 
61, ADL 61) and severely impaired sport and recreation 
function (KOOS: sport/recreation 30) with associated 
reduction in QOL (KOOS: QOL 38), only few had radio-
graphic osteoarthritis (8%). Single-leg muscle function 
was impaired with reductions of 15%–17% in the affected 
leg compared with the non-affected leg in knee extensor 
strength, hop performance and knee bends.
Comparing the two groups at 2 years, the 95% CI (−3.4 
to 19.8) of the primary outcome KOOS5 included the 
prespecified clinically relevant difference of 10, and a 
Variable N
Arthroscopic 
partial 
meniscectomy
N
Skin incisions 
only
N
Total
Min MaxMean (SD) Mean (SD) Mean (SD)
EQ-5D
  VAS score 21 69 (14) 20 63 41 66 (19) 25 95
  EQ-5D-3L index value (0–1) 21 0.749 (0.108) 20 0.642 41 0.697 (0.148) 0.293 1.000
SF-36
  Physical component summary (0–100) 21 38 (10) 20 35 41 37 (9) 17 55
  Mental component summary (0–100) 21 59 (7) 20 57 41 58 (7) 43 70
Performance and muscle function
  One leg hop test (affected knee), cm 21 54 (33) 20 52 41 53 (33) 0 130
  One leg hop test (non-affected knee), cm 21 64 (30) 20 64 41 64 (30) 4 126
  One leg hop LSI*, % 84 81 83
  Knee bending test, max number of knee 
bends (affected knee), n
21 18 (8) 20 15 41 17 (8) 4 33
  Knee bending test, max number of knee 
bends (non-affected knee), n
21 21 (7) 20 19 41 20 (7) 8 33
  Knee bendings LSI*, % 86 79 85
  Isometric knee extensor strength (affected 
knee), Nm/kg
21 0.96 (0.59) 20 0.78 41 0.87 (0.55) 0.00 2.06
  Isometric knee extensor strength (non-
affected knee), Nm/kg
21 1.11 (0.49) 20 0.99 41 1.05 (0.47) 0.33 2.06
  Isometric knee extensor strength LSI*, % 86 79 83
Data are presented as mean and SD unless otherwise stated.
*LSI is calculated as 100 (unaffected leg–affected leg).
BMI,  body mass index; ICRS,International Cartilage Repair Society; KOOS, Knee injury and Osteoarthritis Outcome Score; LSI, Limb 
Symmetry Index; SF-36, Short-Form 36 items; VAS, Visual Analogue Scale. 
Table 1 Continued 
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true difference between groups in favour of arthroscopic 
partial meniscectomy cannot be excluded. Secondary 
outcomes largely supported the primary outcome.
The results of this trial, with regard to the observed treat-
ment effect on pain of either partial meniscectomy or sham 
surgery, are well within the envelope of previous trials of 
arthroscopic surgery for painful knee.5 6
The use of a sham surgery comparator increased the rigour 
of our trial at the 3-month follow-up but not necessarily at 
the primary end point at 2 years because a high proportion 
of patients were non-blinded between 3 and 24 months. At 
3 months in the skin-incisions group, 48% thought they 
received the real treatment and 70% were certain the treat-
ment would help them. In the surgery group, 70% thought 
they received the real treatment and 50% believed the treat-
ment would help them. While four patients (two from the 
skin-incision group) were non-blinded prior to 3 months, 
an additional 10 (eight from the skin-incisions group) were 
non-blinded between 3 and 24 months.
This study had several major limitations that highlight 
the well-known challenges to perform randomised surgery 
trials controlled with sham surgery.23 First, we managed 
to include only 60% of the estimated number of patients 
needed, resulting in low statistical power. Second, 36% 
(16/44) of patients were non-blinded in the course of the 
study, which may have enhanced the placebo effects in the 
surgery group and negatively impacted the patient-reported 
outcomes in the sham-surgery group through nocebo 
effects.24 In our trial, 45% (10/22) of patients randomised 
to skin incisions only were non-blinded. Third, 8 of the 10 
non-blinded patients in the skin-incision-only group crossed-
over to meniscus resection, which further confounded the 
interpretation of the results. Taken together, these limita-
tions markedly hampered our ability to generalise these 
results to the greater patient population. If we had managed 
to recruit the originally planned number of patients, fewer 
patients would have been non-blinded and fewer patients 
would have crossed over, a more firm interpretation of the 
results would have been possible.
Future trialists may consider increasing the number of 
recruiting centres in multicentre studies and providing 
extensive training in research methodology not only for 
Figure 2 Least square mean for each group over time for the primary outcome (KOOS5) for intention-to-treat (A) and per-
protocol (B) analyses. Solid lines represent the arthroscopic partial meniscectomy group and stipled lines the skin incision only 
group. KOOS5, the mean score across all five normalised Knee injury and Osteoarthritis Outcome Score subscales.
Figure 3 Forest plot illustrating the contrast between the 
treatment arms after 2 years for intention-to-treat (A) and per-
protocol (B) groups. ADL, Function, daily living; KOOS, Knee 
injury and Osteoarthritis Outcome Score; KOOS5, the mean 
score across all five normalised KOOS subscales; MCS, 
Mental Component Score; PCS, Physical Component Score; 
QOL, quality of life; SF-36. Short-Form 36 items.
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those closely involved in the study but for all personnel in 
the operating theatre to avoid early non-blinding. Prac-
tising consultation scenarios and improved management of 
patients with persistent pain during follow-up visits may help 
avoid the cross-overs often seen in those being non-blinded 
before or after 3 months by the treating surgeon. In 
Denmark, patients and their GPs have easy digital access to 
patient records, including perioperative reports, and are 
thus able to reveal group allocation without contacting the 
study personnel. This was the case for two patients in our 
study where non-blinding could not be avoided.
COnClusIOn
We found greater improvement from arthroscopic partial 
meniscectomy compared with skin incisions only at 2 years, 
with uncertainty around the between-group difference 
depending on what is considered a clinically relevant differ-
ence between groups. Because of the study being under-
powered, nearly half in the sham group being non-blinded 
and one-third crossing over to surgery, the results cannot be 
generalised to the greater patient population.
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